Philip Astley-Sparke's Net Worth
$19.2 Million
Who is Philip Astley-Sparke?
Philip Astley-Sparke has an estimated net worth of $19.2 Million. This is based on reported shares across multiple companies, which include Replimune Group, Inc., uniQure N.V., and Forbion European Acquisition Corp..
SEC CIK
Philip Astley-Sparke's CIK is 0001376491
Past Insider Trading and Trends
2021 was Philip Astley-Sparke's most active year for acquiring shares with 4 total transactions. Philip Astley-Sparke's most active month to acquire stocks was the month of March. 2019 was Philip Astley-Sparke's most active year for disposing of shares, totalling 16 transactions. Philip Astley-Sparke's most active month to dispose stocks was the month of December. 2020 saw Philip Astley-Sparke paying a total of $0.00 for 270,683 shares, this is the most they've acquired in one year. In 2021 Philip Astley-Sparke cashed out on 50,504 shares for a total of $2,206,740.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Replimune Group, Inc. (REPL) Snapshot price: $7.41
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.49% | -37.93K |
$6.47 | -$245,394.16 | 1.49M |
May 16
| |||
Form 4
| -1.16% | -17.90K |
$18.05 | -$323,131.10 | 1.53M |
May 16
| |||
Form 4
| +10.14% | 142.1K |
—
|
—
| 1.54M |
Apr 1
| |||
Form 4
| -0.68% | -9.63K |
$14.59 | -$140,530.88 | 1.4M |
May 16
| |||
Form 4
| +5.22% | 70K |
—
|
—
| 1.41M |
Apr 1
| |||
Form 4
| +6.80% | 85.42K |
—
|
—
| 1.34M |
Apr 1
| |||
Form 4
| -3.83% | -50.00K |
$43.76 | -$2,187,789.71 | 1.26M |
Scheduled
|
Jan 14 - Jan 19
| ||
Form 4
| -3.69% | -50.00K |
$43.40 | -$2,169,873.59 | 1.31M |
Scheduled
|
Dec 9 - Dec 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| -2.09% | -29.00K |
$17.01 | -$493,290.00 | 1.36M |
Scheduled
|
Nov 6
| ||
Form 4
| -2.05% | -29.00K |
$17.03 | -$493,754.00 | 1.38M |
Scheduled
|
Nov 4
| ||
Form 4
| -1.02% | -14.50K |
$17.00 | -$246,500.00 | 1.41M |
Scheduled
|
Oct 31
| ||
Form 4
| -1.01% | -14.50K |
$17.05 | -$247,225.00 | 1.43M |
Scheduled
|
Sep 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
uniQure N.V. (QURE) Snapshot price: $5.655
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.82% | -504.00 |
$37.60 | -$18,950.40 | 9.95K |
Mar 2
| |||
Form 4
| +29.52% | 2.38K |
—
|
—
| 10.45K |
Feb 25
| |||
Form 4
| +34.35% | 2.06K |
—
|
—
| 8.07K |
Feb 27
| |||
Form 4
| -11.85% | -807.00 |
$59.23 | -$47,798.61 | 6K |
Jan 30
| |||
Form 4
| -48.67% | -6.46K |
$60.12 | -$388,344.00 | 6.81K |
Scheduled
|
Aug 1
| ||
Form 4
| -31.13% | -6.00K |
$63.63 | -$381,779.27 | 13.27K |
Scheduled
|
Jun 3
| ||
Form 4
| -23.74% | -6.00K |
$59.84 | -$359,040.00 | 19.27K |
Scheduled
|
Apr 1
| ||
Form 4
| -4.57% | -1.21K |
$31.32 | -$37,897.20 | 25.27K |
Jan 28
| |||
Form 4
| +13.89% | 3.23K |
—
|
—
| 26.48K |
Jan 25
| |||
Form 4
| -17.70% | -5.00K |
$30.39 | -$151,950.00 | 23.25K |
Scheduled
|
Dec 3
| ||
Form 4
| -18.80% | -6.54K |
$18.53 | -$121,186.20 | 28.25K |
Jan 29
| |||
Form 4
| +15.97% | 4.79K |
—
|
—
| 34.79K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Forbion European Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||